Application Segment Analysis: Diagnostics (Largest Segment) vs Therapeutic (Fastest-Growing Segment)

The diagnostics segment dominated the medical device validation & verification market in 2026, accounting for a 46.64% share, driven by the extensive testing and quality assurance requirements associated with diagnostic devices and systems. These products must demonstrate consistent performance, accuracy, reliability, and safety across varied operating conditions before reaching clinical and laboratory settings. Increasing demand for advanced diagnostic technologies, including connected and software-enabled systems, has further expanded the scope of validation and verification activities. Growing regulatory scrutiny and the need to minimize errors in patient testing also encourage manufacturers to invest in rigorous validation processes throughout product development and lifecycle management.

The therapeutic application segment is the fastest-growing segment, supported by increasing innovation in devices used for treatment, intervention, monitoring, and patient care. Therapeutic technologies often involve complex hardware, software, and integrated functions that require comprehensive verification to ensure intended performance and patient safety. The development of minimally invasive, digitally connected, and personalized treatment solutions is adding further complexity to device design and testing requirements. As manufacturers accelerate the introduction of advanced therapeutic products, demand for specialized validation and verification capabilities is expanding to support regulatory compliance, product reliability, and efficient commercialization.

Therapeutic Area Segment Analysis: Oncology (Largest Segment) vs Nephrology (Fastest-Growing Segment)

In the medical device validation & verification market, the oncology therapeutic area held the largest share in 2026 at 28.62%, reflecting the substantial development activity surrounding devices used in cancer diagnosis, treatment planning, intervention, and patient monitoring. Oncology-focused technologies often require high levels of precision and reliability because device performance can directly influence clinical decision-making and treatment outcomes. Continued innovation in imaging, radiation delivery, surgical systems, and other specialized technologies is increasing the need for rigorous validation across hardware, software, and integrated workflows. The complexity of oncology care and the growing emphasis on technologically advanced treatment approaches continue to support the segment's leading position.

Nephrology represents the fastest-growing therapeutic area segment, driven by increasing demand for advanced technologies supporting kidney disease management and renal care. Devices used in nephrology applications require thorough verification of performance, safety, fluid management, monitoring, and long-term reliability under demanding clinical conditions. Innovation in dialysis technologies, remote monitoring, and connected care systems is also expanding the validation requirements associated with increasingly sophisticated renal devices. As healthcare providers place greater emphasis on improving treatment efficiency and patient management, the development of advanced nephrology technologies is creating stronger demand for specialized validation and verification services.